Barclays PLC Cocrystal Pharma, Inc. Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.48 - $0.71 $72 - $106	-150 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$0.65 - $1.02 $17,234 - $27,045	-26,515 Reduced 99.44%	150 $0
Q3 2021 Nov 09, 2021	BUY	$1.01 - $1.25 $19,204 - $23,767	19,014 Added 248.52%	26,665 $28,000
Q2 2021 Aug 13, 2021	SELL	$1.08 - $2.14 $9,551 - $18,926	-8,844 Reduced 53.62%	7,651 $10,000
Q1 2021 May 13, 2021	BUY	$1.3 - $2.35 $21,443 - $38,763	16,495 New	16,495 $23,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $14.6M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.